Navigation Links
MUHC investigators search for the root of sexual pain in women

A multidisciplinary team consisting of researchers from McGill/MUHC and the CHUM have been awarded a grant of nearly $700,000 by the Canadian Institutes of Health Research (CIHR) to continue their groundbreaking research on pain suffered by some women during sexual intercourse. The new funding will allow the team, consisting of psychologists, gynecologists, physical therapists and statistician/epidemiologists, to root-out the cause of a condition experienced recurrently by at least 15% of Canadian women.

The research team will focus specifically on two main areas of study: dyspareunia (pain during sexual intercourse) and vaginismus (vaginal spasm preventing intercourse). These conditions, which were previously considered sexual dysfunctions, are now increasingly understood as pain disorders as a result of previous research by this team. "Approaching this problem in the context of pain is a more accurate and positive step," says the study's lead researcher Dr. Irv Binik, Director of the Sex and Couple Therapy Service at the MUHC and Professor of Psychology at McGill University. "It opens the door to new therapeutic possibilities including cognitive-behavioral pain management, physical therapy, surgery and alternate pain medication, which will hopefully result in fewer women suffering in silence."

The new CIHR grant will allow the team to initiate research with groups of women that suffer from genital pain associated with menopause--one of the most common forms of dyspareunia. The research concerning vaginismus will focus on the role of fear in sexual intercourse--the major roadblock to therapeutic efforts. "Women suffering from vaginismus seem to avoid and fear vaginal penetration more than women suffering from other genital pain disorders," noted Dr. Binik. "A better understanding of the specific features of both vaginismus and dyspareunia will undoubtedly lead to more appropriate and effective treatments."

Patients who wish to be involved in this study, or wish to learn more about sexual pain in women should contact:


'"/>

Source:McGill University


Related biology news :

1. Gladstone investigators discover how resting T cells avoid HIV infection
2. Gladstone investigators identify a new protective action for the powerful anti-HIV factor, APOBEC3G
3. Researchers discover way to make cells in the eye sensitive to light
4. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
5. Columbia research lifts major hurdle to gene therapy for cancer
6. Researchers find how protein allows insects to detect and respond to pheromones
7. Researchers Uncover Key Step In Manufacture of Memory Protein
8. Research advances quest for HIV-1 vaccine
9. Research on Worms Yields Clues on Aging
10. U of M researcher examines newly emerging deadly disease
11. NYU researchers simulate molecular biological clock
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/12/2017)...  Trovagene, Inc. (NASDAQ: TROV ), a ... that it has signed agreements with seven strategic partners ... Middle East for commercialization of the ... wave of international distribution agreements for Trovagene,s CLIA based ... The initial partners will introduce Trovagene,s liquid biopsy ...
(Date:1/11/2017)... BRUNSWICK, N.J. , Jan. 11, 2017  Michael Johnson, co-founder ... Foundation Venture Capital Group, Inc., has been named to the elite ... Johnson, 27,  was one of 600 people in 20 fields nationwide ... four percent of the 15,000 applicants were selected. ... He is currently a PhD candidate ...
(Date:1/4/2017)... , Jan. 4, 2017  For the thousands of attendees at ... global leader in connected health and biometric measurement devices and services, will ... On display in A&D Medical,s special CES Exhibit Suite ... the ongoing expansion of the company,s WellnessConnected product platform.  ... ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... , ... January 18, 2017 , ... ... and more E&L expertise. Within Albany Molecular Research, Inc. (AMRI), the scientific staff ... past year and is planned for further growth in 2017. Extractable & Leachable ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... and paralysis, today announced that it has submitted a 510(k) to the FDA, ... that utilize MYOLYN’s patent-pending functional electrical stimulation (FES) technology. , The submission ...
(Date:1/18/2017)... ... January 18, 2017 , ... DrugDev customers are ... Ops Executives (Hyatt Regency Miami, January 24-26). DrugDev will join customers including Pfizer, ... such as trial performance metrics, patient enrollment diversity, protocol optimization, and global site ...
(Date:1/18/2017)... ... January 18, 2017 , ... uBiome, the ... paper by its Science Editor, Dr. Elisabeth Bik, in the December 2016 issue ... Bik joined uBiome in October 2016 from her previous position at Stanford University ...
Breaking Biology Technology: